Owlet (OWLT) Stock Analysis & Winston Score
Owlet makes smart baby monitors and health-tracking devices for parents of newborns and infants. Its main product is the Dream Sock, a wearable sensor that clips onto a baby's foot and tracks heart rate, oxygen levels, and sleep patterns. The company sells directly to parents and competes in the consumer baby health market in the United States and a handful of international markets. Owlet earns most of its revenue from hardware sales of its sock and camera monitor products, with some recurring revenue from a subscription app that gives parents access to detailed health data and trend reports. The company is small, with a market cap around $100 million, and its main advantage is brand recognition among new parents in a niche category it helped create. However, Owlet has faced regulatory scrutiny from the FDA over health claims on its devices, and returning to consistent profitability remains the central challenge as it balances product development costs against a limited and slowly growing customer base.
Winston Score: 28/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (6/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (4/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $5.60
Market Cap: $101M
Sector: Healthcare
Industry: Medical - Devices
